Larvol Delta - Benitec-Biopharma-Announces-Acceptance-of-Late-Breaking-Oral-Abstract-for-the-BB301-Phase-1b2a-Clinical-Study-at-the-Muscular-Dystrophy-Association-Clinical-and-Scientic-Conference

Pabparna (BB-301) - Benitec BioPharma

https://www.globenewswire.com/news-release/2025/02/14/3026609/0/en/Benitec-Biopharma-Announces-Acceptance-of-Late-Breaking-Oral-Abstract-for-the-BB-301-Phase-1b-2a-Clinical-Study-at-the-Muscular-Dystrophy-Association-Clinical-and-Scientific-Confer.html

Feb 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next